These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 36799619

  • 1. Complement receptor C5aR1 blockade reprograms tumor-associated macrophages and synergizes with anti-PD-1 therapy in gastric cancer.
    Zhang P, Gu Y, Wang J, Lv K, Lin C, Zhang H, Li H, He H, Li R, Liu H, Xu J.
    Int J Cancer; 2023 Jul 01; 153(1):224-237. PubMed ID: 36799619
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Blockade of V-domain immunoglobulin suppressor of T-cell activation reprograms tumour-associated macrophages and improves efficacy of PD-1 inhibitor in gastric cancer.
    Cao Y, Yu K, Zhang Z, Gu Y, Gu Y, Li W, Zhang W, Shen Z, Xu J, Qin J.
    Clin Transl Med; 2024 Feb 01; 14(2):e1578. PubMed ID: 38356419
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Siglec-9+ tumor-associated macrophages delineate an immunosuppressive subset with therapeutic vulnerability in patients with high-grade serous ovarian cancer.
    Wang Y, He M, Zhang C, Cao K, Zhang G, Yang M, Huang Y, Jiang W, Liu H.
    J Immunother Cancer; 2023 Sep 01; 11(9):. PubMed ID: 37709296
    [Abstract] [Full Text] [Related]

  • 8. Targeting MS4A4A on tumour-associated macrophages restores CD8+ T-cell-mediated antitumour immunity.
    Li Y, Shen Z, Chai Z, Zhan Y, Zhang Y, Liu Z, Liu Y, Li Z, Lin M, Zhang Z, Liu W, Guan S, Zhang J, Qian J, Ding Y, Li G, Fang Y, Deng H.
    Gut; 2023 Nov 24; 72(12):2307-2320. PubMed ID: 37507218
    [Abstract] [Full Text] [Related]

  • 9. Immunosuppressive TREM2(+) macrophages are associated with undesirable prognosis and responses to anti-PD-1 immunotherapy in non-small cell lung cancer.
    Zhang H, Liu Z, Wen H, Guo Y, Xu F, Zhu Q, Yuan W, Luo R, Lu C, Liu R, Gu J, Ge D.
    Cancer Immunol Immunother; 2022 Oct 24; 71(10):2511-2522. PubMed ID: 35278107
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hedgehog-induced PD-L1 on tumor-associated macrophages is critical for suppression of tumor-infiltrating CD8+ T cell function.
    Petty AJ, Dai R, Lapalombella R, Baiocchi RA, Benson DM, Li Z, Huang X, Yang Y.
    JCI Insight; 2021 Mar 22; 6(6):. PubMed ID: 33749663
    [Abstract] [Full Text] [Related]

  • 14. Sophoridine suppresses macrophage-mediated immunosuppression through TLR4/IRF3 pathway and subsequently upregulates CD8+ T cytotoxic function against gastric cancer.
    Zhuang H, Dai X, Zhang X, Mao Z, Huang H.
    Biomed Pharmacother; 2020 Jan 22; 121():109636. PubMed ID: 31733580
    [Abstract] [Full Text] [Related]

  • 15. Blockade of C5a receptor unleashes tumor-associated macrophage antitumor response and enhances CXCL9-dependent CD8+ T cell activity.
    Luan X, Lei T, Fang J, Liu X, Fu H, Li Y, Chu W, Jiang P, Tong C, Qi H, Fu Y.
    Mol Ther; 2024 Feb 07; 32(2):469-489. PubMed ID: 38098230
    [Abstract] [Full Text] [Related]

  • 16. CDK4/6 inhibition promotes immune infiltration in ovarian cancer and synergizes with PD-1 blockade in a B cell-dependent manner.
    Zhang QF, Li J, Jiang K, Wang R, Ge JL, Yang H, Liu SJ, Jia LT, Wang L, Chen BL.
    Theranostics; 2020 Feb 07; 10(23):10619-10633. PubMed ID: 32929370
    [Abstract] [Full Text] [Related]

  • 17. C5aR1 shapes a non-inflammatory tumor microenvironment and mediates immune evasion in gastric cancer.
    Shen H, Gu X, Li X, Xiang Z, Zhang R, Shi F, Tang M, Li H, Zhu G, Su F, Wang Z.
    Biomol Biomed; 2023 May 01; 23(3):392-404. PubMed ID: 36508191
    [Abstract] [Full Text] [Related]

  • 18. Poor Clinical Outcomes and Immunoevasive Contexture in Intratumoral IL-10-Producing Macrophages Enriched Gastric Cancer Patients.
    Zhang H, Li R, Cao Y, Gu Y, Lin C, Liu X, Lv K, He X, Fang H, Jin K, Fei Y, Chen Y, Wang J, Liu H, Li H, Zhang H, He H, Zhang W.
    Ann Surg; 2022 Apr 01; 275(4):e626-e635. PubMed ID: 32541216
    [Abstract] [Full Text] [Related]

  • 19. DKK1 Promotes Tumor Immune Evasion and Impedes Anti-PD-1 Treatment by Inducing Immunosuppressive Macrophages in Gastric Cancer.
    Shi T, Zhang Y, Wang Y, Song X, Wang H, Zhou X, Liang K, Luo Y, Che K, Wang X, Pan Y, Liu F, Yang J, Liu Q, Yu L, Liu B, Wei J.
    Cancer Immunol Res; 2022 Dec 02; 10(12):1506-1524. PubMed ID: 36206576
    [Abstract] [Full Text] [Related]

  • 20. CD226 identifies functional CD8+T cells in the tumor microenvironment and predicts a better outcome for human gastric cancer.
    Huang H, Huang Z, Ge J, Yang J, Chen J, Xu B, Wu S, Zheng X, Chen L, Zhang X, Jiang J.
    Front Immunol; 2023 Dec 02; 14():1150803. PubMed ID: 37056782
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.